SDTM001 Injection as Adjuvant Therapy for NSCLC Patients After Radical Surgical Resection
SDTM001 Injection as Adjuvant Therapy for NSCLC Patients After Radical Surgical Resection
Recruiting · NCT07096882 · Registry updated 2025-07-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SDTM001 Injection as Adjuvant Therapy for NSCLC Patients After Radical Surgical Resection | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 1 | 2025-07-31 | NCT07096882 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cytocraft Biopharmaceutical Co., Ltd. | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| West China Hospital of Sichuan University | Chengdu | China | 23 |